WHO Urges Global Collaboration for Mpox Control

Brussels has declared a worldwide health emergency in response to the mpox epidemic, particularly due to the emergence of the more lethal clade I variant spreading in Europe and Asia. The World Health Organization (WHO) has highlighted the need for vaccination campaigns in affected countries, as the new clade Ib variant has been linked to cases contracted in Africa. While the risk of infection remains low for the general population in Belgium, the Ministry of Public Health is preparing to ensure public safety through targeted immunization efforts. Belgium's public health authorities have stated that mass inoculation is not currently necessary, as the disease primarily affects a minority of individuals, particularly in less organized regions. However, the government is ready to respond if the situation escalates. They have stockpiled 20,000 smallpox vaccines, which are effective against related viruses, and these will be distributed across various regions. Vaccination may require two doses within 28 days for optimal protection, particularly for those at higher risk, including travelers returning from affected areas. WHO Regional Director for Europe, Hans Kluge, emphasized that unlike Covid-19, mpox can be controlled, and he called for global collaboration to manage the epidemic effectively. He noted that while the situation in several African countries appears stable, the interconnectedness of global health means that outbreaks can have far-reaching consequences, as evidenced by a confirmed case in Sweden linked to travel in East-Central Africa. Mpox typically presents with mild symptoms, including skin rashes and flu-like signs, and spreads primarily through close contact. Preventive measures are particularly crucial for women, as maternal infections can impact newborns. Individuals in high-risk environments, especially those in close quarters with infected persons, are urged to take precautions to mitigate the spread of the virus.